Condition: Hyperkalemia · Sponsor: Vifor Pharma, Inc.
A study to evaluate the pharmacodynamic effects, safety, and tolerability of patiromer in children under 12 years of age with hyperkalaemia.
This description comes directly from the study's public registry record.
EMERALD-2 Clinical Study Team · +41 58 851 80 00 · clinicaltrials@cslbehring.com
Always discuss trial participation with your own doctor first.
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| UF Health Pediatric Multispecialty Center Site | Jacksonville, Florida, United States | Terminated |
| Miller School of Medicine, University of Miami | Miami, Florida, United States | Recruiting |
| Arnold Palmer Hospital for Children | Orlando, Florida, United States | Recruiting |
| Augusta University - Children's Hospital of Georgia | Augusta, Georgia, United States | Recruiting |
| University of Illinois College of Medicine | Peoria, Illinois, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Children's Mercy Hospitals and Clinics | Kansas City, Missouri, United States | Recruiting |
| Northwell Health Cohen Children's Medical Center | New York, New York, United States | Not Yet Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
| The Children's Hospital of Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Vanderbilt Children's Hospital Neurology | Nashville, Tennessee, United States | Recruiting |
+ 25 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05766839